NEOGENOMICS, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/52f344ff-9cef-44ab-a2ef-49b67d5f06cc/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-115.9M | 2025-01-01 – 2025-12-31 | evidence 0001077183-26-000010 |
| FY 2024 | $-92.1M | 2024-01-01 – 2024-12-31 | evidence 0001077183-25-000028 |
| FY 2023 | $-107.7M | 2023-01-01 – 2023-12-31 | evidence 0001077183-24-000011 |
| FY 2022 | $-157.6M | 2022-01-01 – 2022-12-31 | evidence 0001077183-23-000023 |
| FY 2021 | $-118.8M | 2021-01-01 – 2021-12-31 | evidence 0001077183-22-000017 |
| FY 2020 | $-14.0M | 2020-01-01 – 2020-12-31 | evidence 0001077183-21-000064 |
| FY 2019 | $13.0M | 2019-01-01 – 2019-12-31 | evidence 0001077183-20-000022 |
| FY 2018 | $10.0M | 2018-01-01 – 2018-12-31 | evidence 0001077183-19-000008 |
| FY 2017 | $2.9M | 2017-01-01 – 2017-12-31 | evidence 0001077183-19-000008 |
| FY 2016 | $2.2M | 2016-01-01 – 2016-12-31 | evidence 0001077183-19-000008 |
| FY 2015 | $-5.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014868 |
| FY 2014 | $2.2M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-075318 |
| FY 2013 | $3.2M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-064714 |
| FY 2012 | $1.2M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-068680 |
| FY 2011 | $-409.0k | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-109860 |
| FY 2010 | $-3.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-109860 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).